CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the use of donor-derived regulatory T cells as a treatment for graft versus host disease following stem cell transplants. It aims to determine the effectiveness of different preparation strategies and the potential need for additional therapeutic agents to enhance treatment outcomes.
Our proposal encompasses parallel clinical trials addressing the feasibility and the effectiveness of donor-derived regulatory T cells (Treg) as a therapeutic agent in the treatment and prevention of tissue and organ damage resulting from graft versus host disease (GVHD) after hematopoietic stem cell transplantation (HSCT).We propose a collaborative clinical study in which Treg therapy for GHVD is the common dominator.
However, by bringing together several clinical centers with expertise in this…
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
KLINIKUM DER UNIVERSITAET REGENSBURG
Germany, Regensburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Liege
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Bologna
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
